We are a decentralized group at the forefront of psychiatry

Elata Biosciences is a community-governed collective funding and supporting early-stage R&D on novel small-molecule psychiatric medicines. Stakeholders of Elata choose what research we support, contribute to governance decisions, and advance the fight against mental health disorders.

Join our community

Our mission is to advance psychiatry using novel governance mechanisms, community, and precision medicine.

15% +

Of people - or close to 800 million - struggle with a mental health disorder globally.
‍

‍

Several

Psychiatric conditions do not have a specified approved medicine available, while the ones that do generally are insufficient for patients.
‍

$20bn +

Is the estimated value of the global psychiatric IP market, yet has major issues with liquidity and capital allocation.
‍
‍

6.2%

Of psychiatric medicine is approved from Phase 1 under the industry's current 'trial-and-error' model, prompting an urgent need for precision psychiatry.

The Elata model is more iterative and symbiotic than the incumbent

For funders

Elata bridges the gap between community needs and current progress in the pharmaceutical industry. With community ownership and involvement, we’re giving an edge in getting new compounds to market. Advances in blockchain technology have unlocked a new paradigm in crowdfunding, collective ownership, liquidity, and diversification. Pharmaceutical companies now can de-risk their investment while increasing engagement and alignment on key incentives with their stakeholders.

For researchers

Elata is forming a psychiatric innovation unit to advance novel compound research, inviting pioneering researchers to steer early-stage drug development.

Elata aims to unify the psychiatric research community, enhancing collaboration and aligning incentives through a community-focused approach.

For patients

Developing an open community that patients can use is the key and most important part of Elata.

We prioritize patient outcomes by fostering an open community, ensuring that scientific advancements and funding interests align closely with the needs of patients.

Frequently Asked Questions

How does Elata work?

We are an open science project focused on the early-stage development of psychiatric molecules, operating within an area known as decentralized science (DeSci). The DeSci movement aims to use blockchain networks to create an open ecosystem around scientific research, ranging from many distinct therapeutic areas and align incentives for all stakeholders.

What is the advantage of Elata?

Elata's advantage lies in its decentralized autonomous organization (DAO) structure, which streamlines collaboration and aligns incentives, directly benefiting investors, scientists, and patients alike.

How can I get involved?

We’re growing our community ahead of our token launch. To get involved, you can follow us on X or join our Discord community.